Core--Tissue culture laboratory
核心--组织培养实验室
基本信息
- 批准号:6663354
- 负责人:
- 金额:$ 21.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A centralized tissue culture facility is more economical than individual investigators perform their own cell culture. The proposed core would be an expansion to accommodate this program project of a tissue culture core that has been in operation since 1980 in the Division of Endocrinology. Reasons for establishing and maintaining a common tissue culture core include the following: 1. Quality control of cell lines, culture techniques, and solutions 2. Bulk preparation of cells and media gives an economical advantage 3. Optimal use of time, equipment and supplies 4. Experienced technicians 5. Consistency between preparations A centralized tissue culture facility is the most efficient means for maintaining cell lines. The cell lines are catalogued and frozen as back-up stocks in liquid nitrogen tanks equipped with alarm systems to prevent loss of important cell lines. All cell lines are screened for mycoplasma detection twice per year. Purchase of fetal calf serum and media in bulk is certainly more cost-effective. Prescreening of 3 to 4 sources of serum for optimal cell growth before purchase is most efficiently accomplished in the core facility. Media and PBS can be prepared at 10, 20, or 30 liters at a time and then tested before use. Bulk ordering of plasticware is also more cost effective. The incubators and hoods are checked and maintained on a periodic basis at specific scheduled times.
集中的组织培养设施比个体研究者自己进行细胞培养更经济。拟议的核心将是一个扩展,以适应自1980年以来一直在运行的内分泌科组织培养核心的计划项目。建立和维持一个共同的组织培养核心的原因包括以下几点:1。细胞系、培养技术和溶液的质量控制2.大量制备细胞和培养基具有经济优势3.最佳利用时间、设备和用品4.技术人员5名。制备之间的一致性集中的组织培养设施是维持细胞系的最有效手段。将细胞系分类并冷冻在配备有警报系统的液氮罐中作为备用储备,以防止重要细胞系的损失。每年对所有细胞系进行两次支原体检测筛查。大量购买胎牛血清和培养基肯定更具成本效益。在核心设施中最有效地完成购买前对3至4种血清来源进行预筛选以获得最佳细胞生长。培养基和PBS可以一次制备10、20或30升,然后在使用前进行测试。大量订购塑料器皿也更具成本效益。在特定的预定时间定期检查和维护培养箱和通风柜。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lynda F Bonewald其他文献
Estrogen Receptor a (ERα) Expression in Osteocytes is Necessary to Maintain Normal Bone Mineral Density (BMD) and Reduce Bone Loss due to Unloading
骨细胞中雌激素受体 a (ERα) 的表达对于维持正常骨矿物质密度 (BMD) 和减少卸载引起的骨损失是必要的
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
Shino Kondoh;Yuuki Imai;Lynda F Bonewald;Shigeaki Kato - 通讯作者:
Shigeaki Kato
Lynda F Bonewald的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lynda F Bonewald', 18)}}的其他基金
Bone and Muscle Interaction: the Mechanical and Beyond
骨骼和肌肉的相互作用:机械及超越
- 批准号:
9762488 - 财政年份:2019
- 资助金额:
$ 21.52万 - 项目类别:
ASBMR Symposium: Cutting Edge Discoveries in Muscle Biology, Disease and Therapeu
ASBMR 研讨会:肌肉生物学、疾病和治疗的前沿发现
- 批准号:
8652013 - 财政年份:2013
- 资助金额:
$ 21.52万 - 项目类别:
OSTEOCYTE REGULATION OF BONE/MUSCLE WITH AGING
骨细胞对骨骼/肌肉衰老的调节
- 批准号:
10166739 - 财政年份:2012
- 资助金额:
$ 21.52万 - 项目类别:
OSTEOCYTE REGULATION OF BONE/MUSCLE WITH AGING
骨细胞对骨骼/肌肉衰老的调节
- 批准号:
9789122 - 财政年份:2012
- 资助金额:
$ 21.52万 - 项目类别:
Effects of the Muscle Factor Beta-aminoisobutyric acid, BAIBA, in Old and Young Osteocytes
肌肉因子 β-氨基异丁酸 (BAIBA) 对老年和年轻骨细胞的影响
- 批准号:
10166743 - 财政年份:2012
- 资助金额:
$ 21.52万 - 项目类别:
ASBMR Topical Meeting on Bone and Skeletal Muscle Interactions
ASBMR 骨与骨骼肌相互作用专题会议
- 批准号:
8400113 - 财政年份:2012
- 资助金额:
$ 21.52万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 21.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 21.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 21.52万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 21.52万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 21.52万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 21.52万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 21.52万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 21.52万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 21.52万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 21.52万 - 项目类别:
Studentship














{{item.name}}会员




